目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. USTEKINUMAB MARKET, BY INDICATION (USD BILLION)
6.1. Psoriasis
6.2. Psoriatic Arthritis
6.3. Crohn's Disease
6.4. Ulcerative Colitis

7. USTEKINUMAB MARKET, BY ADMINISTRATION ROUTE (USD BILLION)
7.1. Subcutaneous
7.2. Intravenous

8. USTEKINUMAB MARKET, BY END USER (USD BILLION)
8.1. Hospitals
8.2. Specialty Clinics
8.3. Homecare

9. USTEKINUMAB MARKET, BY DISTRIBUTION CHANNEL (USD BILLION)
9.1. Hospital Pharmacies
9.2. Retail Pharmacies
9.3. Online Pharmacies

10. USTEKINUMAB MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA

11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Ustekinumab Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Ustekinumab Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023

12. COMPANY PROFILES
12.1. Sanofi
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Merck
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Johnson and Johnson
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. Eli Lilly
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Gilead Sciences
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Novartis
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. AstraZeneca
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. Amgen
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. AbbVie
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. Biogen
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. BristolMyers Squibb
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Celgene
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. Roche
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. Pfizer
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
12.15. Regeneron Pharmaceuticals
12.15.1. Financial Overview
12.15.2. Products Offered
12.15.3. Key Developments
12.15.4. SWOT Analysis
12.15.5. Key Strategies

13. APPENDIX
13.1. References
13.2. Related Reports

LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 7. US USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 8. US USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 9. US USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 10. US USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 11. US USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 12. CANADA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 13. CANADA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 17. EUROPE USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 18. EUROPE USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 19. EUROPE USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 22. GERMANY USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 23. GERMANY USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 24. GERMANY USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 25. GERMANY USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 27. UK USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 28. UK USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 29. UK USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 30. UK USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 31. UK USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. FRANCE USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 33. FRANCE USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 34. FRANCE USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 35. FRANCE USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 36. FRANCE USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 37. RUSSIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 38. RUSSIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 39. RUSSIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 40. RUSSIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 41. RUSSIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 42. ITALY USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 43. ITALY USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 44. ITALY USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 45. ITALY USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 46. ITALY USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 47. SPAIN USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 48. SPAIN USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 49. SPAIN USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 50. SPAIN USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 51. SPAIN USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 52. REST OF EUROPE USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 53. REST OF EUROPE USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 54. REST OF EUROPE USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 55. REST OF EUROPE USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 56. REST OF EUROPE USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 57. APAC USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 58. APAC USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 59. APAC USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 60. APAC USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 61. APAC USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. CHINA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 63. CHINA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 64. CHINA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 65. CHINA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 66. CHINA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 67. INDIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 68. INDIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 69. INDIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 70. INDIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 71. INDIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 72. JAPAN USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 73. JAPAN USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 74. JAPAN USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 75. JAPAN USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 76. JAPAN USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 77. SOUTH KOREA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 78. SOUTH KOREA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 79. SOUTH KOREA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 80. SOUTH KOREA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 81. SOUTH KOREA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 82. MALAYSIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 83. MALAYSIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 84. MALAYSIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 85. MALAYSIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 86. MALAYSIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 87. THAILAND USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 88. THAILAND USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 89. THAILAND USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 90. THAILAND USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 91. THAILAND USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 92. INDONESIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 93. INDONESIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 94. INDONESIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 95. INDONESIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 96. INDONESIA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 97. REST OF APAC USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 98. REST OF APAC USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 99. REST OF APAC USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 100. REST OF APAC USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 101. REST OF APAC USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 102. SOUTH AMERICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 103. SOUTH AMERICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 104. SOUTH AMERICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 105. SOUTH AMERICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 106. SOUTH AMERICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 107. BRAZIL USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 108. BRAZIL USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 109. BRAZIL USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 110. BRAZIL USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 111. BRAZIL USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 112. MEXICO USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 113. MEXICO USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 114. MEXICO USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 115. MEXICO USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 116. MEXICO USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 117. ARGENTINA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 118. ARGENTINA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 119. ARGENTINA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 120. ARGENTINA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 121. ARGENTINA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 127. MEA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 128. MEA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 129. MEA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 130. MEA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 131. MEA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 132. GCC COUNTRIES USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 133. GCC COUNTRIES USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 134. GCC COUNTRIES USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 135. GCC COUNTRIES USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 136. GCC COUNTRIES USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 137. SOUTH AFRICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 138. SOUTH AFRICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 139. SOUTH AFRICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 140. SOUTH AFRICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 141. SOUTH AFRICA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 142. REST OF MEA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY INDICATION, 2019-2032 (USD BILLIONS)
TABLE 143. REST OF MEA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY ADMINISTRATION ROUTE, 2019-2032 (USD BILLIONS)
TABLE 144. REST OF MEA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 145. REST OF MEA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2032 (USD BILLIONS)
TABLE 146. REST OF MEA USTEKINUMAB MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP

LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA USTEKINUMAB MARKET ANALYSIS
FIGURE 3. US USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 4. US USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 5. US USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 6. US USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 7. US USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 9. CANADA USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 10. CANADA USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 11. CANADA USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 12. CANADA USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE USTEKINUMAB MARKET ANALYSIS
FIGURE 14. GERMANY USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 15. GERMANY USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 16. GERMANY USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 17. GERMANY USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 18. GERMANY USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 20. UK USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 21. UK USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 22. UK USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 23. UK USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 25. FRANCE USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 26. FRANCE USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 27. FRANCE USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 28. FRANCE USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 30. RUSSIA USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 31. RUSSIA USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 32. RUSSIA USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 33. RUSSIA USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 35. ITALY USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 36. ITALY USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 37. ITALY USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 38. ITALY USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 40. SPAIN USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 41. SPAIN USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 42. SPAIN USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 43. SPAIN USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 45. REST OF EUROPE USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 46. REST OF EUROPE USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 47. REST OF EUROPE USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 48. REST OF EUROPE USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC USTEKINUMAB MARKET ANALYSIS
FIGURE 50. CHINA USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 51. CHINA USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 52. CHINA USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 53. CHINA USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 54. CHINA USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 56. INDIA USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 57. INDIA USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 58. INDIA USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 59. INDIA USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 61. JAPAN USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 62. JAPAN USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 63. JAPAN USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 64. JAPAN USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 66. SOUTH KOREA USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 67. SOUTH KOREA USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 68. SOUTH KOREA USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 69. SOUTH KOREA USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 71. MALAYSIA USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 72. MALAYSIA USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 73. MALAYSIA USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 74. MALAYSIA USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 76. THAILAND USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 77. THAILAND USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 78. THAILAND USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 79. THAILAND USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 81. INDONESIA USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 82. INDONESIA USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 83. INDONESIA USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 84. INDONESIA USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 86. REST OF APAC USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 87. REST OF APAC USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 88. REST OF APAC USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 89. REST OF APAC USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA USTEKINUMAB MARKET ANALYSIS
FIGURE 91. BRAZIL USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 92. BRAZIL USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 93. BRAZIL USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 94. BRAZIL USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 95. BRAZIL USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 97. MEXICO USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 98. MEXICO USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 99. MEXICO USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 100. MEXICO USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 102. ARGENTINA USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 103. ARGENTINA USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 104. ARGENTINA USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 105. ARGENTINA USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 107. REST OF SOUTH AMERICA USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 108. REST OF SOUTH AMERICA USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 109. REST OF SOUTH AMERICA USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 110. REST OF SOUTH AMERICA USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA USTEKINUMAB MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 113. GCC COUNTRIES USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 114. GCC COUNTRIES USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 115. GCC COUNTRIES USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 116. GCC COUNTRIES USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 118. SOUTH AFRICA USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 119. SOUTH AFRICA USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 120. SOUTH AFRICA USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 121. SOUTH AFRICA USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA USTEKINUMAB MARKET ANALYSIS BY INDICATION
FIGURE 123. REST OF MEA USTEKINUMAB MARKET ANALYSIS BY ADMINISTRATION ROUTE
FIGURE 124. REST OF MEA USTEKINUMAB MARKET ANALYSIS BY END USER
FIGURE 125. REST OF MEA USTEKINUMAB MARKET ANALYSIS BY DISTRIBUTION CHANNEL
FIGURE 126. REST OF MEA USTEKINUMAB MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF USTEKINUMAB MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF USTEKINUMAB MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: USTEKINUMAB MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: USTEKINUMAB MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: USTEKINUMAB MARKET
FIGURE 133. USTEKINUMAB MARKET, BY INDICATION, 2024 (% SHARE)
FIGURE 134. USTEKINUMAB MARKET, BY INDICATION, 2019 TO 2032 (USD Billions)
FIGURE 135. USTEKINUMAB MARKET, BY ADMINISTRATION ROUTE, 2024 (% SHARE)
FIGURE 136. USTEKINUMAB MARKET, BY ADMINISTRATION ROUTE, 2019 TO 2032 (USD Billions)
FIGURE 137. USTEKINUMAB MARKET, BY END USER, 2024 (% SHARE)
FIGURE 138. USTEKINUMAB MARKET, BY END USER, 2019 TO 2032 (USD Billions)
FIGURE 139. USTEKINUMAB MARKET, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
FIGURE 140. USTEKINUMAB MARKET, BY DISTRIBUTION CHANNEL, 2019 TO 2032 (USD Billions)
FIGURE 141. USTEKINUMAB MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 142. USTEKINUMAB MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS